Hypercholesterolemia, Hyperlipidemia
Conditions
Brief summary
This is a study to assess the safety, efficacy, and tolerability of MK0859 in patients with primary hypercholesterolemia (large amounts of cholesterol in the blood) or mixed hyperlipidemia (high levels of LDL cholesterol, triglycerides, and low levels of HDL cholesterol in blood) This is an early phase trial and some specific protocol information is in progress and not publicly available at this time. (Full information is available to trial participants).
Interventions
DRUGMK0859
Sponsors
Merck Sharp & Dohme LLC
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE
Eligibility
Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No
Inclusion criteria
* Patient is between 18 and 75 years of age * Patient can be on a stable diet for the study * Patient has a stable weight for more then 6 weeks before the study and has not participated in a weight loss program
Exclusion criteria
* Patient has chronic heart failure or a history of heart disease * Patient has blood, digestive, or central nervous system disorders * Patient is pregnant or nursing * Patient is HIV positive
Outcome results
None listed